Can a Rat Breathe through a Mouse's Lung?
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0706ED. Online ahead of print.NO ABSTRACTPMID:38701370 | DOI:10.1164/rccm.202404-0706ED (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Munemasa Mori Wellington V Cardoso Source Type: research
Pulmonary Hypertension and Lung Damage Associated with Prolonged Exposure to Patent Ductus Arteriosus in Very Preterm Infants
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0694ED. Online ahead of print.NO ABSTRACTPMID:38701371 | DOI:10.1164/rccm.202404-0694ED (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Eduardo Villamor Gema E Gonzalez-Luis Source Type: research
Electrical Impedance Tomography: A Monitoring Tool for Ventilation Induced Lung Injury
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202311-2121LE. Online ahead of print.NO ABSTRACTPMID:38701379 | DOI:10.1164/rccm.202311-2121LE (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Isabella Fratti Tommaso Pozzi Guenter Hahn Antonio Fioccola Rosmery V Nicolardi Mattia Busana Francesca Collino Onnen Moerer Luigi Camporota Luciano Gattinoni Source Type: research
Molecular Characterization of the Distal Lung: Novel Insights from COPD Omics
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202310-1972PP. Online ahead of print.NO ABSTRACTPMID:38701385 | DOI:10.1164/rccm.202310-1972PP (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Peter J Castaldi Maor Sauler Source Type: research
We Can Use Machine Learning to Predict Obstructive Sleep Apnea
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202403-0666ED. Online ahead of print.NO ABSTRACTPMID:38701391 | DOI:10.1164/rccm.202403-0666ED (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Richard J Schwab Guray Erus Source Type: research
Strategies for Identifying Biomarkers in Severe Asthma
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0707ED. Online ahead of print.NO ABSTRACTPMID:38701409 | DOI:10.1164/rccm.202404-0707ED (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Pierre-Olivier Girodet Source Type: research
Pulmonary Ionocytes: What Are They Transporting and Which Way?
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0727ED. Online ahead of print.NO ABSTRACTPMID:38701428 | DOI:10.1164/rccm.202404-0727ED (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Kenichi Okuda Martina Gentzsch Source Type: research
Reply to van der Sar < em > et al. < /em > : Classifying Interstitial Lung Disease: Omics Are in the Air
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0777LE. Online ahead of print.NO ABSTRACTPMID:38701441 | DOI:10.1164/rccm.202404-0777LE (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Yong Huang Shwu-Fan Ma Imre Noth Source Type: research
Resilience and Stress Are Heterogenic Too, We Should Act Accordingly
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202403-0648LE. Online ahead of print.NO ABSTRACTPMID:38701443 | DOI:10.1164/rccm.202403-0648LE (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: G Jan Zijlstra Source Type: research
Classifying Interstitial Lung Disease: Omics Are in the Air
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0748LE. Online ahead of print.NO ABSTRACTPMID:38701488 | DOI:10.1164/rccm.202404-0748LE (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Iris G van der Sar Catharina C Moor Marlies S Wijsenbeek Source Type: research
Reply to Zijlstra: Resilience and Stress Are Heterogenic Too, We Should Act Accordingly
Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0790LE. Online ahead of print.NO ABSTRACTPMID:38701491 | DOI:10.1164/rccm.202404-0790LE (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Elie Azoulay Fr édéric Pochard Laurent Argaud Nancy Kentish-Barnes Source Type: research
Exploring Definitions and Predictors of Severe Asthma Clinical Remission Post-Biologic in Adults
CONCLUSIONS: One in 5 patients achieved 4-domain remission within 1-year of biologic-initiation. Patients with less severe impairment and shorter asthma duration at initiation had a greater chance of achieving remission post-biologic, indicating that biologic treatment should not be delayed if remission is the goal. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).PMID:38701495 | DOI:10.1164/rccm.202311-2192OC (Source: Respiratory Care)
Source: Respiratory Care - May 3, 2024 Category: Respiratory Medicine Authors: Luis Perez-de-Llano Ghislaine Scelo Trung N Tran Tham T Le Malin Fareg ås Borja G Cosio Matthew Peters Paul E Pfeffer Mona Al-Ahmad Riyad O Al-Lehebi Alan Altraja Celine Bergeron Leif H Bjermer Anne S Bjerrum Lakmini Bulathsinhala John Busby Diana J Cano Source Type: research
Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice
CONCLUSIONS: Neoadjuvant treatment with a combination of immunotherapy plus chemotherapy appears to achieve higher radiological and pathological responses than monotherapy for IIA-IIIB NSCLC. Log-rank analysis showed that a better outcome could be expected in patients with the addition of immunotherapy to neoadjuvant chemotherapy if compared with patients with chemotherapy alone in terms of DFS.PMID:38693705 | DOI:10.1111/crj.13761 (Source: Respiratory Care)
Source: Respiratory Care - May 2, 2024 Category: Respiratory Medicine Authors: Xiaojie Huang Guanchao Pang Zhirong Mao Baizhou Li Zhihua Teng Yan Yang Zijian Qiu Xiuxiu Chen Pingli Wang Source Type: research
A randomized trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment
CONCLUSIONS: This study failed to detect a difference in ppFEV1 recovery between adjuvant oral prednisone and placebo treatment in pwCF not responding at day 7 of IV antibiotic therapy for PExs.PMID:38697648 | DOI:10.1183/13993003.02278-2023 (Source: Respiratory Care)
Source: Respiratory Care - May 2, 2024 Category: Respiratory Medicine Authors: Valerie Waters Michelle Shaw Lucy Perrem Bradley S Quon Elizabeth Tullis Melinda Solomon Jonathan H Rayment Annick Lavoie Sze Man Tse Patrick Daigneault Lara Bilodeau April Price Michael Nicholson Melanie Chin Michael Parkins Martha L McKinney Julian S Ta Source Type: research
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors
CONCLUSION: PI may induce PAH in patients undergoing treatment, with Carfilzomib emitting a stronger signal than Bortezomib, and these patients should be monitored closely.PMID:38697649 | DOI:10.1183/13993003.02158-2023 (Source: Respiratory Care)
Source: Respiratory Care - May 2, 2024 Category: Respiratory Medicine Authors: Julien Grynblat Charles Khouri Alex Hlavaty Xavier Jais Laurent Savale Marie Camille Chaumais Mithum Kularatne Mitja Jevnikar Ath énaïs Boucly Fabrice Antigny Fr édéric Perros G érald Simonneau Olivier Sitbon Marc Humbert David Montani French PH Netw Source Type: research
